Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-06-24
1987-11-17
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546139, 546144, A61K 3147, C07D21720
Patent
active
047074850
ABSTRACT:
Compounds having the formula ##STR1## are .beta.-adrenergic receptor antagonists. Also disclosed are pharmaceutical compositions and methods for producing .beta.-adrenergic receptor antagonistic activity in animals including man.
REFERENCES:
patent: 3910915 (1975-10-01), Yonan
patent: 4514569 (1985-04-01), Hendrickson
Kiyomoto, A. et al., Arzneim-Forsch. (Drug. Res.), 20: 46-52 (1970).
Yamoto et al., Tetrahedron Supp. 8, pt. 1, 129 (1966).
Iwasawa, Y. and Kiyomoto, A., Jap. J. Pharmacol., 17: 143-152 (1967).
Dyke, S. F. et al., Tetrahedron 29: 857-862.
Perchonock, C. D. et al., J. Org. Chem., 45: 1950-1953 (1980).
Chemical Abstract, 52: 3832b (1956).
Chemical Abstract, 90: 121442 (1978).
Chemical Abstract, 60: 79926 (1964).
Kaiser Carl
Kruse Lawrence I.
Bond Robert T.
Fabiano Vincent L.
Lourie Alan D.
Morris Patricia L.
SmithKline Beckman Corporation
LandOfFree
Substituted te[1]trahydroisoquinoline derivatives having .beta.- does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted te[1]trahydroisoquinoline derivatives having .beta.-, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted te[1]trahydroisoquinoline derivatives having .beta.- will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1450378